Cardiovascular Involvement

  • George E. Tzelepis
  • Clio P. Mavragani
  • Haralampos M. Moutsopoulos


Cardiac involvement occurs rarely in primary Sjögren’s syndrome (pSS), with the majority of descriptions coming primarily from single case reports or small patient series. In this respect, pSS differs from other systemic autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis, or systemic sclerosis, in which cardiac complications are quite common [1].


Systemic Lupus Erythematosus Pulmonary Arterial Hypertension Interstitial Lung Disease Autonomic Dysfunction Autonomic Neuropathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Riboldi P, Gerosa M, Luzzana C, et al. Cardiac involvement in systemic autoimmune diseases. Clin Rev Allergy Immunol. 2002;23:247–61.PubMedCrossRefGoogle Scholar
  2. 2.
    Chen HA, Chen CH, Cheng HH. Hemolytic uremic syndrome and pericarditis as early manifestations of primary Sjogren’s syndrome. Clin Rheumatol. 2009;28 Suppl 1:S43–6.PubMedCrossRefGoogle Scholar
  3. 3.
    Gyongyosi M, Pokorny G, Jambrik Z, et al. Cardiac manifestations in primary Sjogren’s ­syndrome. Ann Rheum Dis. 1996;55:450–4.PubMedCrossRefGoogle Scholar
  4. 4.
    Suzuki H, Hickling P, Lyons CB. A case of primary Sjogren’s syndrome, complicated by ­cryoglobulinaemic glomerulonephritis, pericardial and pleural effusions. Br J Rheumatol. 1996;35:72–5.PubMedCrossRefGoogle Scholar
  5. 5.
    Mohri H, Kimura M, Ieki R, et al. Cardiac tamponade in Sjogren’s syndrome. J Rheumatol. 1986;13:830–1.PubMedGoogle Scholar
  6. 6.
    Launay D, Hachulla E, Hatron PY, et al. Pulmonary arterial hypertension: a rare complication of primary Sjogren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore). 2007;86:299–315.CrossRefGoogle Scholar
  7. 7.
    Vassiliou VA, Moyssakis I, Boki KA, et al. Is the heart affected in primary Sjogren’s syndrome? An echocardiographic study. Clin Exp Rheumatol. 2008;26:109–12.PubMedGoogle Scholar
  8. 8.
    Manganelli P, Bernardi P, Taliani U, et al. Echocardiographic findings in primary Sjogren’s syndrome. Ann Rheum Dis. 1997;56:568.PubMedCrossRefGoogle Scholar
  9. 9.
    Mita S, Akizuki S, Koido N, et al. Cardiac involvement in Sjögren’s syndrome detected by two dimensional ultrasonic cardiography. In: Homma M et al., editors. Sjögren’s syndrome – state of the art. Amsterdam: Kugler; 1994. p. 427–30.Google Scholar
  10. 10.
    Rantapaa-Dahlqvist S, Backman C, Sandgren H, et al. Echocardiographic findings in patients with primary Sjogren’s syndrome. Clin Rheumatol. 1993;12:214–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Yoong JK, Chew LC, Quek R, et al. Cardiac lymphoma in primary Sjogren syndrome: a novel case established by targeted imaging and pericardial window. J Thorac Cardiovasc Surg. 2007;134:513–4.PubMedCrossRefGoogle Scholar
  12. 12.
    Kau CK, Hu JC, Lu LY, et al. Primary Sjogren’s syndrome complicated with cryoglobulinemic glomerulonephritis, myocarditis, and multi-organ involvement. J Formos Med Assoc. 2004;103:707–10.PubMedGoogle Scholar
  13. 13.
    Levin MD, Zoet-Nugteren SK, Markusse HM. Myocarditis and primary Sjogren’s syndrome. Lancet. 1999;354:128–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Yoshioka K, Tegoshi H, Yoshida T, et al. Myocarditis and primary Sjogren’s syndrome. Lancet. 1999;354:1996.PubMedCrossRefGoogle Scholar
  15. 15.
    Baumgart DC, Gerl H, Dorner T. Complete heart block caused by primary Sjogren’s syndrome and hypopituitarism. Ann Rheum Dis. 1998;57:635.PubMedCrossRefGoogle Scholar
  16. 16.
    Lee LA, Pickrell MB, Reichlin M. Development of complete heart block in an adult patient with Sjogren’s syndrome and anti-Ro/SS-A autoantibodies. Arthritis Rheum. 1996;39:1427–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Lodde BM, Sankar V, Kok MR, et al. Adult heart block is associated with disease activity in primary Sjogren’s syndrome. Scand J Rheumatol. 2005;34:383–6.PubMedCrossRefGoogle Scholar
  18. 18.
    Skopouli FN, Dafni U, Ioannidis JP, et al. Clinical evolution, and morbidity and mortality of primary Sjogren’s syndrome. Semin Arthritis Rheum. 2000;29:296–304.PubMedCrossRefGoogle Scholar
  19. 19.
    Theander E, Manthorpe R, Jacobsson LT. Mortality and causes of death in primary Sjogren’s syndrome: a prospective cohort study. Arthritis Rheum. 2004;50:1262–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Gerli R, Bartoloni BE, Vaudo G, et al. Traditional cardiovascular risk factors in primary Sjogren’s syndrome–role of dyslipidaemia. Rheumatology (Oxford). 2006;45:1580–1.CrossRefGoogle Scholar
  21. 21.
    Gerli R, Vaudo G, Bocci EB, et al. Functional impairment of arterial wall in primary Sjogren’s syndrome: combined action of immunological and inflammatory factors. Arthritis Care Res (Hoboken). 2010;62:712–8.CrossRefGoogle Scholar
  22. 22.
    Vaudo G, Bocci EB, Shoenfeld Y, et al. Precocious intima-media thickening in patients with primary Sjogren’s syndrome. Arthritis Rheum. 2005;52:3890–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Abou-Raya A, Abou-Raya S. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. Autoimmun Rev. 2006;5:331–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Lodde BM, Sankar V, Kok MR, et al. Serum lipid levels in Sjogren’s syndrome. Rheumatology (Oxford). 2006;45:481–4.CrossRefGoogle Scholar
  25. 25.
    Ramos-Casals M, Brito-Zeron P, Siso A, et al. High prevalence of serum metabolic alterations in primary Sjogren’s syndrome: influence on clinical and immunological expression. J Rheumatol. 2007;34:754–61.PubMedGoogle Scholar
  26. 26.
    Asherson RA, Hughes GR. Pulmonary hypertension in Sjogren’s syndrome. Ann Rheum Dis. 1988;47:703–4.PubMedCrossRefGoogle Scholar
  27. 27.
    Bertoni M, Niccoli L, Porciello G, et al. Pulmonary hypertension in primary Sjogren’s ­syndrome: report of a case and review of the literature. Clin Rheumatol. 2005;24:431–4.PubMedCrossRefGoogle Scholar
  28. 28.
    Sato T, Matsubara O, Tanaka Y, et al. Association of Sjogren’s syndrome with pulmonary hypertension: report of two cases and review of the literature. Hum Pathol. 1993;24:199–205.PubMedCrossRefGoogle Scholar
  29. 29.
    Andonopoulos AP, Ballas C. Autonomic cardiovascular neuropathy in primary Sjogren’s ­syndrome. Rheumatol Int. 1995;15:127–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Barendregt PJ, Markusse HM, Man In’t Veld AJ. Primary Sjogren’s syndrome presenting as autonomic neuropathy. Case report. Neth J Med. 1998;53:196–200.PubMedCrossRefGoogle Scholar
  31. 31.
    Goto H, Matsuo H, Fukudome T, et al. Chronic autonomic neuropathy in a patient with ­primary Sjogren’s syndrome. J Neurol Neurosurg Psychiatry. 2000;69:135.PubMedCrossRefGoogle Scholar
  32. 32.
    Kondo T, Inoue H, Usui T, et al. Autoimmune autonomic ganglionopathy with Sjogren’s ­syndrome: significance of ganglionic acetylcholine receptor antibody and therapeutic approach. Auton Neurosci. 2009;146:33–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Sakakibara R, Hirano S, Asahina M, et al. Primary Sjogren’s syndrome presenting with generalized autonomic failure. Eur J Neurol. 2004;11:635–8.PubMedCrossRefGoogle Scholar
  34. 34.
    Shimoyama M, Ohtahara A, Okamura T, et al. Isolated autonomic cardiovascular neuropathy in a patient with primary Sjogren syndrome: a case of successful treatment with glucocorticoid. Am J Med Sci. 2002;324:170–2.PubMedCrossRefGoogle Scholar
  35. 35.
    Sorajja P, Poirier MK, Bundrick JB, et al. Autonomic failure and proximal skeletal myopathy in a patient with primary Sjogren syndrome. Mayo Clin Proc. 1999;74:695–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Wright RA, Grant IA, Low PA. Autonomic neuropathy associated with sicca complex. J Auton Nerv Syst. 1999;75:70–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Mori K, Iijima M, Koike H, et al. The wide spectrum of clinical manifestations in Sjogren’s syndrome-associated neuropathy. Brain. 2005;128:2518–34.PubMedCrossRefGoogle Scholar
  38. 38.
    Andonopoulos AP, Christodoulou J, Ballas C, et al. Autonomic cardiovascular neuropathy in Sjogren’s syndrome. A controlled study. J Rheumatol. 1998;25:2385–8.PubMedGoogle Scholar
  39. 39.
    Mandl T, Bornmyr SV, Castenfors J, et al. Sympathetic dysfunction in patients with primary Sjogren’s syndrome. J Rheumatol. 2001;28:296–301.PubMedGoogle Scholar
  40. 40.
    Mandl T, Wollmer P, Manthorpe R, et al. Autonomic and orthostatic dysfunction in primary Sjogren’s syndrome. J Rheumatol. 2007;34:1869–74.PubMedGoogle Scholar
  41. 41.
    Mandl T, Granberg V, Apelqvist J, et al. Autonomic nervous symptoms in primary Sjogren’s syndrome. Rheumatology (Oxford). 2008;47:914–9.CrossRefGoogle Scholar
  42. 42.
    Stojanovich L, Milovanovich B, de Luka SR, et al. Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjogren syndrome and other autoimmune ­diseases. Lupus. 2007;16:181–5.PubMedGoogle Scholar
  43. 43.
    Tumiati B, Perazzoli F, Negro A, et al. Heart rate variability in patients with Sjogren’s ­syndrome. Clin Rheumatol. 2000;19:477–80.PubMedCrossRefGoogle Scholar
  44. 44.
    Goldstein DS, Holmes C, Imrich R. Clinical laboratory evaluation of autoimmune autonomic ganglionopathy: preliminary observations. Auton Neurosci. 2009;146:18–21.PubMedCrossRefGoogle Scholar
  45. 45.
    Barendregt PJ, van den Bent MJ, van Raaij-van den Aarssen VJ, et al. Involvement of the peripheral nervous system in primary Sjogren’s syndrome. Ann Rheum Dis. 2001;60:876–81.PubMedGoogle Scholar
  46. 46.
    Niemela RK, Pikkujamsa SM, Hakala M, et al. No signs of autonomic nervous system dysfunction in primary Sjogren’s syndrome evaluated by 24 hour heart rate variability. J Rheumatol. 2000;27:2605–10.PubMedGoogle Scholar
  47. 47.
    Niemela RK, Hakala M, Huikuri HV, et al. Comprehensive study of autonomic function in a population with primary Sjogren’s syndrome. No evidence of autonomic involvement. J Rheumatol. 2003;30:74–9.PubMedGoogle Scholar
  48. 48.
    Fox RI, Stern M. Sjogren’s syndrome: mechanisms of pathogenesis involve interaction of immune and neurosecretory systems. Scand J Rheumatol Suppl. 2002;116:3–13.PubMedGoogle Scholar
  49. 49.
    Gordon TP, Bolstad AI, Rischmueller M, et al. Autoantibodies in primary Sjogren’s syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis. Autoimmunity. 2001;34:123–32.PubMedCrossRefGoogle Scholar
  50. 50.
    Stojanovich L. Autonomic dysfunction in autoimmune rheumatic disease. Autoimmun Rev. 2009;8:569–72.PubMedCrossRefGoogle Scholar
  51. 51.
    Law WG, Thong BY, Lian TY, et al. Acute lupus myocarditis: clinical features and outcome of an oriental case series. Lupus. 2005;14:827–31.PubMedCrossRefGoogle Scholar
  52. 52.
    Jais X, Launay D, Yaici A, et al. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum. 2008;58:521–31.PubMedCrossRefGoogle Scholar
  53. 53.
    Sanchez O, Sitbon O, Jais X, et al. Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. Chest. 2006;130:182–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  • George E. Tzelepis
    • 1
  • Clio P. Mavragani
    • 1
  • Haralampos M. Moutsopoulos
    • 1
  1. 1.Department of PathophysiologyUniversity of Athens Medical School, Laiko University HospitalAthensGreece

Personalised recommendations